[EN] C-TERMINAL SRC KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE SRC C-TERMINALE
申请人:INVENTISBIO SHANGHAI LTD
公开号:WO2020125615A1
公开(公告)日:2020-06-25
Provided herein are novel C-terminal Srk Kinase (CSK) inhibitors, e.g., having Formula G, I, II, or III. Also provided are methods of preparing the novel CSK inhibitors and method of using the novel CSK inhibitors for treating diseases or disorder such as cancer or for promoting immune response in a subject in need thereof. (G)
本文提供了新型C端Srk激酶(CSK)抑制剂,例如具有G、I、II或III式的抑制剂。还提供了制备新型CSK抑制剂的方法以及利用这些新型CSK抑制剂治疗癌症等疾病或紊乱的方法,或者用于促进需要的主体的免疫反应。